These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344 [TBL] [Abstract][Full Text] [Related]
4. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. Gillies MC; Simpson JM; Gaston C; Hunt G; Ali H; Zhu M; Sutter F Ophthalmology; 2009 Nov; 116(11):2182-7. PubMed ID: 19796823 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema. Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024 [TBL] [Abstract][Full Text] [Related]
6. [Triamcinolone in the treatment of the diabetic macular edema--one-year results]. Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg. Hauser D; Bukelman A; Pokroy R; Katz H; Len A; Thein R; Parness-Yossifon R; Pollack A Retina; 2008 Jun; 28(6):825-30. PubMed ID: 18536598 [TBL] [Abstract][Full Text] [Related]
8. Macular function after intravitreal triamcinolone acetonide injection for diabetic macular oedema. Karacorlu M; Ozdemir H; Senturk F; Karacorlu SA; Uysal O Acta Ophthalmol; 2010 Aug; 88(5):558-63. PubMed ID: 19432873 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Avitabile T; Longo A; Reibaldi A Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation. Negi AK; Vernon SA; Lim CS; Owen-Armstrong K Eye (Lond); 2005 Jul; 19(7):747-51. PubMed ID: 15359268 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Ciardella AP; Klancnik J; Schiff W; Barile G; Langton K; Chang S Br J Ophthalmol; 2004 Sep; 88(9):1131-6. PubMed ID: 15317702 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy. Cho WB; Moon JW; Kim HC Br J Ophthalmol; 2010 Jul; 94(7):858-63. PubMed ID: 20606024 [TBL] [Abstract][Full Text] [Related]
20. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract. Habib MS; Cannon PS; Steel DH BMC Ophthalmol; 2005 Jun; 5():15. PubMed ID: 15972106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]